Viewing Study NCT01697540



Ignite Creation Date: 2024-05-06 @ 12:56 AM
Last Modification Date: 2024-10-26 @ 10:57 AM
Study NCT ID: NCT01697540
Status: COMPLETED
Last Update Posted: 2018-08-09
First Post: 2012-09-28

Brief Title: Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization: Kaohsiung Medical University Chung-Ho Memorial Hospital

Study Overview

Official Title: Tropical Medicine Center TMC Kaohsiung Medicine University Hospital KMUH
Status: COMPLETED
Status Verified Date: 2017-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: 1 Written informed consent must be obtained before any study specific procedures are undertaken
2 The process of the experiment brief describe The patients must come back for follow during 4 to 12 weeks after starting the new therapy The investigators will follow the patients lipid profile and any side effects and stop the observation till 36 months after starting the new therapy The serum level of HIV-VL CD4 GOT GPT triglyceride cholesterol HDL-cholesterol and LDL-cholesterol will be checked every 3 months The patients chart and all data will be delinked to protect the patients right and privacy
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None